Clinical trials in Herlev – page 3

303 clinical trials in Herlev, Denmark across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in DenmarkKliniske-Forsoeg.dk

Herlev at a glance

303

clinical trials

Research sites2

Quick filters

303 trials in Herlev

Open in trial search

Pancreatic carcinoma metastatic

Recruiting

Comparing Daraxonrasib Alone or Combined with Gemcitabine and Paclitaxel Albumin‑Bound vs Standard Chemotherapy in Patients with Metastatic Pancreatic Adenocarcinoma

Registered drugNo placebo

Comparing Daraxonrasib Alone or Combined with Gemcitabine and Paclitaxel Albumin‑Bound vs Standard Chemotherapy in Patients with Metastatic Pancreatic Adenocarcinoma

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Gemcitabine
Sponsor:Revolution Medicines Inc.

Contact Research Centre

Colorectal cancer metastatic

Recruiting

Study of precemtabart tocentecan alone or in drug combination versus standard therapy in previously treated metastatic colorectal cancer patients

Registered drugNo placebo

Study of precemtabart tocentecan alone or in drug combination versus standard therapy in previously treated metastatic colorectal cancer patients

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Bevacizumab
Sponsor:Merck Healthcare KGaA

Contact Research Centre

Osteosarcoma

Recruiting

Cabozantinib Maintenance Therapy vs Best Supportive Care in Osteosarcoma Patients in Complete Remission or with Residual Disease after First‑Line Chemotherapy

Registered drugNo placebo

Cabozantinib Maintenance Therapy vs Best Supportive Care in Osteosarcoma Patients in Complete Remission or with Residual Disease after First‑Line Chemotherapy

Registered drugNo placebo

Denmark

Participants:0–17 years · 18–64 years · 65+ years
Substances:Cabozantinib
Sponsor:Institut Gustave Roussy

Contact Research Centre

Sedative therapy

Recruiting

Patient‑controlled remimazolam, alfentanil and midazolam sedation for outpatients undergoing colonoscopy: safety, efficacy and satisfaction study

Registered drugNo placebo

Patient‑controlled remimazolam, alfentanil and midazolam sedation for outpatients undergoing colonoscopy: safety, efficacy and satisfaction study

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Midazolam
Sponsor:Rigshospitalet

Contact Research Centre

Pancreatic carcinoma metastatic

Recruiting

Randomized Study of INCB161734 Plus Standard Chemotherapy Drug Combination in Untreated KRAS G12D Metastatic Pancreatic Ductal Adenocarcinoma Patients

Registered drug

Randomized Study of INCB161734 Plus Standard Chemotherapy Drug Combination in Untreated KRAS G12D Metastatic Pancreatic Ductal Adenocarcinoma Patients

Registered drug

Denmark

Participants:18–64 years · 65+ years
Substances:Calcium Folinate
Sponsor:Incyte Corp.

Contact Research Centre

Osteoarthritis

Recruiting

Efficacy and Safety of LTG-321 Compared with Placebo in Patients with Osteoarthritis of the Knee

Investigational

Efficacy and Safety of LTG-321 Compared with Placebo in Patients with Osteoarthritis of the Knee

Investigational

Denmark

Participants:18–64 years · 65+ years
Sponsor:Latigo Biotherapeutics Inc.

Contact Research Centre

Crohn's disease

Recruiting

A Phase 3b Study of Guselkumab Compared with Risankizumab in Adults with Moderately to Severely Active Crohn’s Disease

Registered drugNo placebo

A Phase 3b Study of Guselkumab Compared with Risankizumab in Adults with Moderately to Severely Active Crohn’s Disease

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Guselkumab
Sponsor:Janssen Cilag International

Contact Research Centre

Renal cell carcinoma

Recruiting

Belzutifan and Zanzalintinib in Adults with Advanced Renal Cell Carcinoma After PD-1/L1 and VEGF-TKI Therapy

Registered drug

Belzutifan and Zanzalintinib in Adults with Advanced Renal Cell Carcinoma After PD-1/L1 and VEGF-TKI Therapy

Registered drug

Denmark

Participants:18–64 years · 65+ years
Substances:Belzutifan
Sponsor:Merck Sharp & Dohme LLC

Contact Research Centre

Stomatitis+1

Recruiting

A study to compare the effectiveness of bupivacaine hydrochloride monohydrate and lidocaine hydrochloride for treating mouth sores in patients with head and neck cancer.

InvestigationalNo placebo

A study to compare the effectiveness of bupivacaine hydrochloride monohydrate and lidocaine hydrochloride for treating mouth sores in patients with head and neck cancer.

InvestigationalNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Lidocaine Hydrochloride

Contact Research Centre

Endometrial cancer+12

Recruiting

A study of belzutifan and lenvatinib for patients with von Hippel-Lindau disease-associated tumors or other specific solid tumors.

InvestigationalNo placebo

A study of belzutifan and lenvatinib for patients with von Hippel-Lindau disease-associated tumors or other specific solid tumors.

InvestigationalNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Belzutifan
Sponsor:Merck Sharp & Dohme LLC

Contact Research Centre

Ovarian cancer

Recruiting

A study of sacituzumab tirumotecan and bevacizumab in patients with newly diagnosed advanced ovarian cancer following first-line platinum-based chemotherapy

Registered drugNo placebo

A study of sacituzumab tirumotecan and bevacizumab in patients with newly diagnosed advanced ovarian cancer following first-line platinum-based chemotherapy

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Bevacizumab
Sponsor:Merck Sharp & Dohme LLC

Contact Research Centre

Cardiac failure+1

Recruiting

Study of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity

Investigational

Study of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity

Investigational

Denmark

Participants:18–64 years · 65+ years
Sponsor:Novo Nordisk A/S

Contact Research Centre

Other cities in Denmark

The busiest research cities in the country

All 48 cities in Denmark

Clinical research in Herlev

What the registry says about research in the country

01 Oncology Research

Innovative clinical trials focusing on advanced cancer treatments, particularly in endometrial, prostate, and bladder cancers. Studies are evaluating novel combination therapies and immunological approaches.

Endometrial Cancer Treatment Studies
Metastatic Prostate Cancer Therapies
Bladder Cancer Interventions

Research aims to improve treatment outcomes and survival rates through targeted therapeutic approaches.

02 Cardiovascular and Metabolic Studies

Comprehensive research into heart failure prevention and treatment of metabolic conditions, including studies on innovative drug combinations and biomarker-targeted approaches.

Heart Failure Prevention Trials
Diabetes and Kidney Disease Research
Obesity Management Studies

Focus on developing preventive strategies and improving patient outcomes in cardiovascular conditions.

03 Preventive Medicine

Studies examining vaccine effectiveness and preventive treatments, particularly in meningococcal and varicella infections. Research includes both pediatric and adult populations.

Meningococcal Vaccine Studies
Chickenpox Vaccination Research
Immunization Response Analysis

Emphasis on developing safe and effective preventive measures for infectious diseases.

Back to Denmark All countries